3-tyr-octreotide has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kato, Y | 1 |
den Holder, F; Hofland, LJ; Koper, JW; Lamberts, SW; van Koetsveld, PM | 1 |
1 review(s) available for 3-tyr-octreotide and Adenoma, Prolactin-Secreting, Pituitary
Article | Year |
---|---|
[Drug therapy of pituitary tumors].
Topics: Bromocriptine; Cushing Syndrome; Cyproheptadine; Female; Humans; Male; Metyrapone; Octreotide; Pituitary Neoplasms; Prolactinoma | 1991 |
1 other study(ies) available for 3-tyr-octreotide and Adenoma, Prolactin-Secreting, Pituitary
Article | Year |
---|---|
Desensitization and resensitization of rat pituitary tumor cells in long-term culture to the effects of the somatostatin analogue SMS 201-995 on cell growth and prolactin secretion.
Topics: Animals; Cell Division; Dose-Response Relationship, Drug; Drug Tolerance; Female; Octreotide; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Receptors, Neurotransmitter; Receptors, Somatostatin; Time Factors; Tumor Cells, Cultured | 1990 |